ConductScience.org, home

Trial · NCT07882758

Union-LC-MPE Cohort:A Multicenter Cohort Study on Diagnosis and Prognosis of Malignant Pleural Effusion in Lung Cance

NCT07882758, Not yet recruiting, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Union-LC-MPE Cohort:A Multicenter Cohort Study on Diagnosis and Prognosis of Malignant Pleural Effusion in Lung Cance. Trials, record NCT07882758. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882758

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Union-LC-MPE Cohort:A Multicenter Cohort Study on Diagnosis and Prognosis of Malignant Pleural Effusion in Lung Cance
NCT number
NCT07882758
Status
Not yet recruiting
Enrollment
3,000 participants, estimated
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions
Malignant Pleural Effusions (Mpe), Lung Cancer (Diagnosis)
First posted
2026-10-20
Last updated
2026-10-27

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryOverall Survival (OS)From date of diagnosis of malignant pleural effusion to death from any cause, or end of study (up to 24 months)
Overall survival (OS) is defined as the time from the date of diagnosis of malignant pleural effusion (MPE) to death from any cause. Patients who are alive or lost to follow-up at the end of the study will be censored at the last known alive date. OS will be compared among different treatment groups using Kaplan-Meier methods and Cox regression analysis.
SecondaryProgression-free survivalFrom date of diagnosis of malignant pleural effusion to documented disease progression or death from any cause, or end of study (up to 24 months)
Progression-free survival (PFS) is defined as the time from the date of diagnosis of malignant pleural effusion (MPE) to the date of documented disease progression or death from any cause, whichever occurs first. Patients who are alive without progression at the end of the study will be censored at the last known progression-free date. PFS will be compared among different treatment groups using Kaplan-Meier methods and Cox regression analysis.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
25100651BACKGROUNDPubMed
38246779BACKGROUNDPubMed
38572751BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07882758

GET https://conductscience.org/api/trials/v1/NCT07882758/registered